Free Trial

Piper Sandler Cuts Marsh & McLennan Companies (NYSE:MRSH) Price Target to $182.00

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Piper Sandler cut its price target on Marsh & McLennan Companies from $190 to $182 while keeping a neutral rating, implying about 10.88% upside from the current share price.
  • Other analysts have also adjusted views on the stock recently, and the broader consensus remains Hold with an average price target of $203.56.
  • Marsh & McLennan reported better-than-expected quarterly earnings, with EPS of $3.29 versus estimates of $3.21 and revenue up 7.6% year over year.
  • Interested in Marsh & McLennan Companies? Here are five stocks we like better.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) had its price objective decreased by analysts at Piper Sandler from $190.00 to $182.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has a "neutral" rating on the financial services provider's stock. Piper Sandler's target price indicates a potential upside of 10.88% from the stock's current price.

Several other brokerages also recently commented on MRSH. Wells Fargo & Company decreased their price objective on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 9th. Raymond James Financial upgraded shares of Marsh & McLennan Companies from an "outperform" rating to a "strong-buy" rating and set a $225.00 price objective on the stock in a research report on Tuesday, February 17th. Bank of America reduced their price target on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an "underperform" rating on the stock in a report on Tuesday, April 14th. Cantor Fitzgerald lifted their price target on shares of Marsh & McLennan Companies from $208.00 to $212.00 and gave the company an "overweight" rating in a report on Monday, February 2nd. Finally, Barclays reduced their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating on the stock in a report on Wednesday, April 8th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $203.56.

Read Our Latest Analysis on MRSH

Marsh & McLennan Companies Price Performance

Shares of MRSH stock opened at $164.14 on Tuesday. The company has a market cap of $79.08 billion, a P/E ratio of 20.52, a price-to-earnings-growth ratio of 2.39 and a beta of 0.65. Marsh & McLennan Companies has a one year low of $158.16 and a one year high of $235.78. The company's fifty day moving average price is $167.35. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, beating the consensus estimate of $3.21 by $0.08. The firm had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business's revenue for the quarter was up 7.6% on a year-over-year basis. Equities research analysts expect that Marsh & McLennan Companies will post 10.37 earnings per share for the current fiscal year.

Insider Activity at Marsh & McLennan Companies

In related news, CEO John Q. Doyle sold 16,655 shares of Marsh & McLennan Companies stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares of the company's stock, valued at approximately $21,411,456.30. The trade was a 12.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.38% of the company's stock.

Hedge Funds Weigh In On Marsh & McLennan Companies

Large investors have recently made changes to their positions in the company. Numerai GP LLC lifted its position in shares of Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider's stock worth $7,501,000 after purchasing an additional 33,729 shares during the period. Swiss Life Asset Management Ltd lifted its position in shares of Marsh & McLennan Companies by 9.5% in the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider's stock worth $24,960,000 after purchasing an additional 11,648 shares during the period. Rockland Trust Co. raised its stake in shares of Marsh & McLennan Companies by 801.6% during the 3rd quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider's stock worth $2,433,000 after acquiring an additional 10,734 shares in the last quarter. Barclays PLC raised its stake in shares of Marsh & McLennan Companies by 41.7% during the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider's stock worth $443,844,000 after acquiring an additional 647,987 shares in the last quarter. Finally, Bridges Investment Management Inc. raised its stake in shares of Marsh & McLennan Companies by 4.4% during the 3rd quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider's stock worth $15,356,000 after acquiring an additional 3,177 shares in the last quarter. 87.99% of the stock is owned by hedge funds and other institutional investors.

About Marsh & McLennan Companies

(Get Free Report)

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Featured Stories

Analyst Recommendations for Marsh & McLennan Companies (NYSE:MRSH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines